SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-021200
Filing Date
2020-08-10
Accepted
2020-08-10 17:17:38
Documents
14
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea125310-8k_cormedix.htm   iXBRL 8-K 26982
2 PRESS RELEASE DATED AUGUST 10, 2020 ea125310ex99-1_cormedix.htm EX-99.1 96127
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8092
  Complete submission text file 0001213900-20-021200.txt   319109

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20200810.xsd EX-101.SCH 3179
5 XBRL LABEL FILE crmd-20200810_lab.xml EX-101.LAB 34581
6 XBRL PRESENTATION FILE crmd-20200810_pre.xml EX-101.PRE 22702
7 EXTRACTED XBRL INSTANCE DOCUMENT ea125310-8k_cormedix_htm.xml XML 3601
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 201090334
SIC: 2834 Pharmaceutical Preparations